Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Delaware Medical Care Associates, LLC
mi
from
Newark, DE
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Delaware Medical Care Associates, LLC
mi
from
Newark, DE
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
LaPorte County Institute for Clinical Research Inc.
mi
from
Michigan City, IN
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Kentucky
mi
from
Lexington, KY
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Toledo College of Medicine
mi
from
Toledo, OH
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Toledo College of Medicine
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
UCLA Division of Rheumatology
mi
from
Los Angeles, CA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
UCLA Division of Rheumatology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Georgetown University School of Medicine
mi
from
Washington,
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Georgetown University School of Medicine
mi
from
Washington,
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
USF Health Faculty Office Building-FOB
mi
from
Tampa, FL
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
USF Health Faculty Office Building-FOB
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Arthritis Research and Treatment Center
mi
from
Stockbridge, GA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Arthritis Research and Treatment Center
mi
from
Stockbridge, GA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Louisiana State Univ.
mi
from
Shreveport, LA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Louisiana State Univ.
mi
from
Shreveport, LA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Boston University of Medicine BUMC
mi
from
Boston, MA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Boston University of Medicine BUMC
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Michigan
mi
from
Ann Arbor, MI
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
UMDNJ-Robert Wood Johnson Medical School Clinical Research Center
mi
from
New Brunswick, NJ
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
UMDNJ-Robert Wood Johnson Medical School Clinical Research Center
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
North Shore-LIJ Health System-Division of Rheumatology
mi
from
Great Neck, NY
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
North Shore-LIJ Health System-Division of Rheumatology
mi
from
Great Neck, NY
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Monash Medical Centre
mi
from
Clayton,
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Monash Medical Centre
mi
from
Clayton,
Click here to add this to my saved trials
Need for the Assessment and Consultation Team (ACT) Following Anesthetic Care
Etiology of Post-anesthetic and Post-sedation Events on the Inpatient Ward: Data From a Rapid Response Team at a Tertiary Care Children's Hospital
Status: Enrolling
Updated:  4/5/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Need for the Assessment and Consultation Team (ACT) Following Anesthetic Care
Etiology of Post-anesthetic and Post-sedation Events on the Inpatient Ward: Data From a Rapid Response Team at a Tertiary Care Children's Hospital
Status: Enrolling
Updated: 4/5/2017
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation
MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation
Status: Enrolling
Updated:  4/6/2017
Center for Discovery
mi
from
Harris, NY
MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation
MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation
Status: Enrolling
Updated: 4/6/2017
Center for Discovery
mi
from
Harris, NY
Click here to add this to my saved trials
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
Registry of Patients Being Treated With Norditropin®, Recombinant Human Growth Hormone
Status: Enrolling
Updated:  4/11/2017
Novo Nordisk Investigational Site
mi
from
Plainsboro, NJ
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
Registry of Patients Being Treated With Norditropin®, Recombinant Human Growth Hormone
Status: Enrolling
Updated: 4/11/2017
Novo Nordisk Investigational Site
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
Near Infrared Spectroscopy in Children With Autism and ADHD
Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children
Status: Enrolling
Updated:  4/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Near Infrared Spectroscopy in Children With Autism and ADHD
Near Infra-Red Spectroscopy (NIRS) in Neurodevelopmental Disorders and Typically Developing Children
Status: Enrolling
Updated: 4/12/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Southern California
mi
from
Los Angeles, CA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Emory University
mi
from
Atlanta, GA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Maryland
mi
from
Baltimore, MD
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
NIH Heart Center at Suburban Hospital
mi
from
Bethesda, MD
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
NIH Heart Center at Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Montefiore Einstein Heart Center
mi
from
Bronx, NY
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Montefiore Einstein Heart Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Columbia University Medical Center
mi
from
New York, NY
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Mission Hospital, Inc
mi
from
Asheville, NC
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Duke University
mi
from
Durham, NC
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Ohio State University
mi
from
Columbus, OH
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
Baylor Research Institute
mi
from
Plano, TX
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Baylor Research Institute
mi
from
Plano, TX
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Virginia
mi
from
Charlottesville, VA
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated:  4/12/2017
University of Alberta Hospital
mi
from
Edmonton,
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
University of Alberta Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
Banner University Medical Center
mi
from
Phoenix, AZ
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
Banner University Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
University of Arizona Medical Center
mi
from
Tucson, AZ
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
University of Arizona Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
University of California, Irvine
mi
from
Irvine, CA
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
Mercy San Juan Medical Center/ Mercy General
mi
from
Sacramento, CA
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
Mercy San Juan Medical Center/ Mercy General
mi
from
Sacramento, CA
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
Los Robles Medical Center
mi
from
Thousand Oaks, CA
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
Los Robles Medical Center
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
Advanced Neuroscience Network/Tenet South Florida
mi
from
Delray Beach, FL
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
Advanced Neuroscience Network/Tenet South Florida
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
South Broward Hospital
mi
from
Hollywood, FL
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
South Broward Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated:  4/14/2017
University of Miami Hospital
mi
from
Miami, FL
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Status: Enrolling
Updated: 4/14/2017
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials